Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Con Sets Up Subsidiary For International Marketing of Agricultural Products; Industry Expert, Rene De S. Palomares To Spearhead Effort.


Business Editors

CARLSBAD, Calif.--(BUSINESS WIRE)--Aug. 14, 2000

US Microbics U.S. Microbics is a biotech holding company. Nicknamed "Bugs", it owns several subsidiaries that utilize its patented microbe technology. Bugs is notable because it is the first US Corporation to build a business around the various commercial uses for microorganisms. , Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: BUGS), announced today that its subsidiary Bio-Con Microbes, Inc. (Bio-Con) has formed a Mexican Corporation to serve as it's international marketing arm for agricultural products and services based upon naturally occurring micro-organisms and additives manufactured by the company.

Gus Olson, President of Bio-Con announced that Rene De S. Palomares has been appointed President of Natura Ag, SA de CV. Olson stated "Sr. Palomares has twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights.
     2.
 experience in manufacturing and marketing bio-rational fertilizers to growers throughout the world. He also has an extensive background in direct farming of high-value crops. A prominent citizen, Sr. Palomares is well known and respected throughout Mexico and Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. ."

Olson continued, "Natura Ag will have responsibility for sales of our products in Mexico and Latin America. Sr. Palomares believes in building on strengths and focusing marketing efforts in those areas where existing business relationships can lead to immediate and profitable sales. Through his extensive network of business contacts, we expect Natura Ag to grow rapidly to take advantage of the large emerging market for microbial microbial

pertaining to or emanating from a microbe.


microbial digestion
the breakdown of organic material, especially feedstuffs, by microbial organisms.
 innoculants. Our further expansion into the international marketplace will provide us with growth and revenue producing opportunities as well as the ability to capture substantial market share. Our initial goal is to ship $200,000 of product during this quarter as we kickoff our south of the border sales."

Sr. Palomares stated, "We have known for a long time that microbial products should be part of the growing system. The overuse overuse Health care The common use of a particular intervention even when the benefits of the intervention don't justify the potential harm or cost–eg, prescribing antibiotics for a probable viral URI. Cf Misuse, Underuse.  of conventional fertilizers has depleted de·plete  
tr.v. de·plet·ed, de·plet·ing, de·pletes
To decrease the fullness of; use up or empty out.



[Latin d
 soil microbiology and has lead to decreased yields, increased soil-borne plant disease, and decreased crop quality. Systems that use microbial innoculants and bio-rational fertilizers will help restore balance to the soil and result in healthier crops. In addition, we can help growers save money by cutting back on fertilizers, pesticides, and fungicides This page aims to list well-known chemical compounds, to stimulate the creation of Wikipedia articles.

This list is not necessarily complete or up to date – if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page
 while at the same time, reducing their adverse impact on our environment. Sustainable growing practices give us a win for the grower, a win for our environment, and result in a very profitable business opportunity for our company.

For information about U.S. Microbics Inc. contact Robert Brehm at 760-918-1860 or for agricultural product information contact Gus Olson at 760-776-8003 or visit online at http://bugsatwork.com. Investor Relations Investor relations

The process by which the corporation communicates with its investors.
: DeMonte Associates- Gail Johnson 212-473-3700/ gjohnson@demonte.com

The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect," or similar expressions that involve risks and uncertainties. These risks and uncertainties include the Company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The Company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the "Risk Factors," "Management's Discussion and Analysis Management's discussion and analysis (MD&A)

A report from management to shareholders that accompanies the firm's financial statements in the annual report. It explains the period's financial results and enables management to discuss topics that may not be apparent in the financial
 or Plan of Operation" and other sections of the Company's Form 10-KSB and other publicly available information regarding the Company on file with the Securities and Exchange Commission. The Company will provide you with copies of this information upon request.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 14, 2000
Words:531
Previous Article:Probex Reports Third Quarter/Nine Months Results.
Next Article:Chindex International, Inc. Announces $0.15 Per Share Earnings For 2nd Quarter And First Ever Profitable Results For Beijing United Family Hospital.



Related Articles
People.
ASSOCIATION PEOPLE.
Autodesk ofrece soluciones completas de diseno. (En La Mira).
FORMER RAMPART COP, 4 OTHERS ARRESTED IN DRUG BUST.
Editor's corner.
Un nuevo nombre en tecnologia; Benq: Brindar entretenimiento y calidad de vida. (En la Mira).
Bolsillo salvador. (Esodicen).
Octava edicion annual Premios Bravo De Negocios nominaciones.
NOBEX/BIOCON TO DEVELOP ORAL INSULIN PRODUCT.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles